Lung Cancer
News
FDA grants full approval to crizotinib for NSCLC indication
News
Partial pleurectomy improved quality of life but not survival in mesothelioma
Major finding: Pleural effusion was controlled at 1 month in 37% of patients in the talc group and in 59% of patients in the pleurectomy group (P...
News
HPV prevalent in Hispanic nonsmokers with EGFR-positive lung cancer
Major finding: Progression-free survival was significantly greater in patients who were EGFR-positive/HPV-positive, compared with those who were...
News
Inspiratory muscle training improved subjective breathlessness in lung cancer
Major finding: Inspiratory muscle training with a pressure threshold device improved self-reported patient measures of breathlessness and other...
News
Cetuximab adds no benefit in stage III unresectable lung cancer
Major finding: Median survival in patients randomized to cetuximab was 23.1 months, compared with 23.5 months in patients not taking cetuximab;...
News
One-third of cancer patients over age 70 went untreated, Swedish study finds
Major finding: Nearly one-third (32.2%) of 659 patients over age 70 with non–small cell lung cancer received no radiotherapy or chemotherapy.Data...
News
Real-world snapshot of lung nodule management raises concerns
Major finding: Of patients sent to surgery for a suspicious lung nodule, 36% had benign disease.Data source: A retrospective study of 385 patients...
News
Onartuzumab plus erlotinib extended overall survival in MET-positive lung cancer
Major finding: In patients with MET-positive tumors, overall survival was nearly three times longer with erlotinib plus onartuzumab (12.6 months)...
News
Stereotactic lung radiotherapy of central lung tumors can achieve good overall survival with limited toxicity
Major finding: Overall survival at 3 years was similar for 100 centrally located non–small cell lung cancers – defined as being located within 2...
News
Osteopontin level in early non-small cell lung cancer predicts recurrence
Major finding: Preoperative plasma osteopontin levels above 49.6 ng/mL are predictive of recurrence of lung adenocarcinoma in patients with early...
News
Molecular profiling leads to improved targeted treatment
Major finding: Forty percent of patients were identified as having a molecular target for which an approved treatment could be given.Data source:...